DeepTech Investor Summit

InvestmentUpdated on 16 January 2026

Unique platform investment opportunity in breakthrough immunogenicity technology

Co-Founder, CEO at ALP Bio AG

Zürich, Switzerland

About

Reach out to me via email. Full tech, business and legal DD available from lead investor.

Stage

  • Pre-Seed

Applies to

  • Artificial Intelligence (AI)
  • Bio Tech

Organisation

ALP Bio AG

ETH spin-off

Zurich, Switzerland

Similar opportunities